{"id":"W3114441670","doi":"10.3390/curroncol28010023","title":"Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single Institution","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Gemcitabine; Medicine; Neutropenia; Oxaliplatin; Internal medicine; Paclitaxel; Pancreatic cancer; Oncology; Chemotherapy; Adverse effect; Gastroenterology; Cancer; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009788083,0.0002630777,0.0006268916,0.0007457244,0.0005516993,0.0006068436,0.0003638257,0.0003460823,0.000588989],"category_scores_gemma":[0.001928386,0.0002124396,0.0006064767,0.001016821,0.000480116,0.0003632668,0.0005764051,0.0003542141,0.0001047366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002259647,"about_ca_system_score_gemma":0.001939431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007394042,"about_ca_topic_score_gemma":0.008497781,"domain_scores_codex":[0.999274,0.000196915,0.0001225616,0.0001391933,0.000133328,0.0001340838],"domain_scores_gemma":[0.9981153,0.0002946898,0.0008813137,0.0001839819,0.0001673169,0.0003574449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002250453,0.000518058,0.9808778,0.00009114447,0.0002896314,0.0004593992,0.0003344564,0.0004912044,0.0007977159,0.00002253184,0.0002029518,0.01366477],"study_design_scores_gemma":[0.0003506262,0.003106125,0.992058,0.00002685886,0.0003426726,0.001059662,0.0003717816,0.0007156791,0.001246325,0.00003069116,0.0006700526,0.0000215221],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995813,0.0002064875,0.00002918024,0.0000132333,0.000001289832,0.00001436996,0.000077784,0.000001542947,0.00007488659],"genre_scores_gemma":[0.9991066,0.0002027615,0.00008782557,0.00004328337,0.000007194553,0.00002603599,0.0004713505,0.000001539255,0.00005348872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007394042,"threshold_uncertainty_score":0.01639491,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1282286079017969,"score_gpt":0.4321734517311451,"score_spread":0.3039448438293482,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}